Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice

Figure 2 Enhanced hepatocellular apoptosis in Recql5-deficient mice after lipopolysaccharide/D-Gal treatment. A: TUNEL assay for apoptotic hepatocytes in wild type (WT) and Recql5-deficient (Recql5^-/-) mice after lipopolysaccharide (LPS)/D-Gal injection; B: Western blot analysis of cleaved caspase-3 protein levels in the livers of WT and Recql5-deficient mice in response to LPS/D-Gal; C: Western blot analysis of γ-H2A.X levels in the livers of WT and Recql5-deficient mice in response to LPS/D-Gal. ^aP < 0.05, WT vs Recql5^-/-.